Howard Hughes Medical Institute, UCLA School of Medicine, Box 951662, Los Angeles, CA 90095-1662, USA.
Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2541-6. doi: 10.1161/ATVBAHA.112.250571. Epub 2012 Aug 30.
Inducible degrader of the low-density lipoprotein receptor (IDOL) is an E3 ubiquitin ligase that mediates the ubiquitination and degradation of the low-density lipoprotein receptor (LDLR). IDOL expression is controlled at the transcriptional level by the cholesterol-sensing nuclear receptor liver X receptor (LXR). In response to rising cellular sterol levels, activated LXR induces IDOL production, thereby limiting further uptake of exogenous cholesterol through the LDLR pathway. The LXR-IDOL-LDLR mechanism for feedback inhibition of cholesterol uptake is independent of and complementary to the sterol regulatory element-binding protein pathway. Since the initial description of the LXR-IDOL pathway, biochemical studies have helped to define the structural basis for both IDOL target recognition and LDLR ubiquitin transfer. Recent work has also suggested links between IDOL and human lipid metabolism.
诱导型低密度脂蛋白受体(IDOL)降解酶是一种 E3 泛素连接酶,介导低密度脂蛋白受体(LDLR)的泛素化和降解。IDOL 的表达受胆固醇感应核受体肝 X 受体(LXR)在转录水平上的控制。为了应对细胞内胆固醇水平的升高,激活的 LXR 诱导 IDOL 的产生,从而通过 LDLR 途径限制外源性胆固醇的进一步摄取。LXR-IDOL-LDLR 机制是胆固醇摄取反馈抑制的独立且互补的途径,与固醇调节元件结合蛋白途径无关。自最初描述 LXR-IDOL 途径以来,生化研究有助于确定 IDOL 靶标识别和 LDLR 泛素转移的结构基础。最近的工作还表明 IDOL 与人类脂质代谢之间存在联系。